estradiol + norethindrone acetate + selective serotonin reuptake inhibitors

This is a combination of three pharmacological agents: - **Estradiol** is a synthetic form of the primary female sex hormone estrogen, used in hormone replacement therapy to alleviate menopausal symptoms and prevent osteoporosis by replacing declining endogenous estrogen levels. - **Norethindrone acetate** is a synthetic progestin (a form of progesterone) that counteracts the effects of unopposed estrogen on the endometrium, reducing the risk of endometrial hyperplasia and cancer when used with estradiol. This combination (estradiol + norethindrone acetate) is commonly prescribed for moderate to severe menopausal symptoms such as hot flashes, night sweats, vaginal atrophy, and for osteoporosis prevention in postmenopausal women[1][2][3][4]. - **Selective serotonin reuptake inhibitors (SSRIs)** are a class of antidepressant medications that increase synaptic serotonin levels by inhibiting its reuptake into presynaptic neurons. SSRIs are primarily indicated for major depressive disorder, anxiety disorders, obsessive-compulsive disorder, and other psychiatric conditions. There is no evidence from available sources that these three agents are co-formulated or marketed as a single pharmaceutical product; rather, they may be co-prescribed in clinical practice for patients who require both hormone replacement therapy and treatment with an SSRI.